Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 19356

Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus are wide; the most frequent indication as per reported by Worldwide Network for Blood and Marrow Transplantation Group (WNBT) (2013) is lymphoproliferative disorder (53.2% of all HSCT), 12% of whom received allogeneic and the rest received autologous transplant. Plasma cell disorders are the most frequent indication in this group. A multitude of literature published by researchers and organizations demonstrate that autologous transplant own a greater edge against allogeneic HSCT.
Over 30 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
In 2018, the global Hematopoietic Stem Cells Transplantation (HSCT) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hematopoietic Stem Cells Transplantation (HSCT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hematopoietic Stem Cells Transplantation (HSCT) development in United States, Europe and China.

The key players covered in this study
Kite Pharma
Thermo Fisher Scientific
CellGenix Technologie Transfer
Cesca Therapeutics
R&D Systems
...

Market segment by Type, the product can be split into
Autologous Transplant
Allogenic Transplant

Market segment by Application, split into
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hematopoietic Stem Cells Transplantation (HSCT) status, future forecast, growth opportunity, key market and key players.
To present the Hematopoietic Stem Cells Transplantation (HSCT) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hematopoietic Stem Cells Transplantation (HSCT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size Growth Rate by Type (2014-2025)
1.4.2 Autologous Transplant
1.4.3 Allogenic Transplant
1.5 Market by Application
1.5.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Share by Application (2014-2025)
1.5.2 Leukemia
1.5.3 Lymphoproliferative Disorders
1.5.4 Solid Tumors
1.5.5 Non-Malignant Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hematopoietic Stem Cells Transplantation (HSCT) Market Size
2.2 Hematopoietic Stem Cells Transplantation (HSCT) Growth Trends by Regions
2.2.1 Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Regions (2014-2025)
2.2.2 Hematopoietic Stem Cells Transplantation (HSCT) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Manufacturers
3.1.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue by Manufacturers (2014-2019)
3.1.2 Global Hematopoietic Stem Cells Transplantation (HSCT) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Concentration Ratio (CR5 and HHI)
3.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players Head office and Area Served
3.3 Key Players Hematopoietic Stem Cells Transplantation (HSCT) Product/Solution/Service
3.4 Date of Enter into Hematopoietic Stem Cells Transplantation (HSCT) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type (2014-2019)
4.2 Global Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application (2014-2019)

5 United States
5.1 United States Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
5.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in United States
5.3 United States Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
5.4 United States Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

6 Europe
6.1 Europe Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
6.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in Europe
6.3 Europe Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
6.4 Europe Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

7 China
7.1 China Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
7.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in China
7.3 China Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
7.4 China Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

8 Japan
8.1 Japan Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
8.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in Japan
8.3 Japan Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
8.4 Japan Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
9.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in Southeast Asia
9.3 Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
9.4 Southeast Asia Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

10 India
10.1 India Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
10.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in India
10.3 India Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
10.4 India Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

11 Central & South America
11.1 Central & South America Hematopoietic Stem Cells Transplantation (HSCT) Market Size (2014-2019)
11.2 Hematopoietic Stem Cells Transplantation (HSCT) Key Players in Central & South America
11.3 Central & South America Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Type
11.4 Central & South America Hematopoietic Stem Cells Transplantation (HSCT) Market Size by Application

12 International Players Profiles
12.1 Kite Pharma
12.1.1 Kite Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hematopoietic Stem Cells Transplantation (HSCT) Introduction
12.1.4 Kite Pharma Revenue in Hematopoietic Stem Cells Transplantation (HSCT) Business (2014-2019)
12.1.5 Kite Pharma Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hematopoietic Stem Cells Transplantation (HSCT) Introduction
12.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells Transplantation (HSCT) Business (2014-2019)
12.2.5 Thermo Fisher Scientific Recent Development
12.3 CellGenix Technologie Transfer
12.3.1 CellGenix Technologie Transfer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hematopoietic Stem Cells Transplantation (HSCT) Introduction
12.3.4 CellGenix Technologie Transfer Revenue in Hematopoietic Stem Cells Transplantation (HSCT) Business (2014-2019)
12.3.5 CellGenix Technologie Transfer Recent Development
12.4 Cesca Therapeutics
12.4.1 Cesca Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hematopoietic Stem Cells Transplantation (HSCT) Introduction
12.4.4 Cesca Therapeutics Revenue in Hematopoietic Stem Cells Transplantation (HSCT) Business (2014-2019)
12.4.5 Cesca Therapeutics Recent Development
12.5 R&D Systems
12.5.1 R&D Systems Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hematopoietic Stem Cells Transplantation (HSCT) Introduction
12.5.4 R&D Systems Revenue in Hematopoietic Stem Cells Transplantation (HSCT) Business (2014-2019)
12.5.5 R&D Systems Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details